Key result
Radiofrequency catheter ablation for SVT in children aged 0-9 years achieved a 97.9% overall acute success rate and 11.6% recurrence rate, with no significant differences in success or recurrence between children aged 0-4 and 5-9 years.
Why the study?
Is radiofrequency catheter ablation safe and effective for supraventricular tachycardia in children aged 0-9 years?
Cohort (n=95)
Is radiofrequency catheter ablation safe and effective for supraventricular tachycardia in children aged 0-9 years?
Radiofrequency catheter ablation is highly effective and safe for treating supraventricular tachycardia in young children, with comparable outcomes between those aged 0-4 and 5-9 years.
Supports RFCA for SVT in young children; leaves open need for RCTs to confirm long-term outcomes.
BACKGROUND: The safety and effectiveness of radiofrequency catheter ablation (RFCA) for supraventricular tachycardia (SVT) in young children was investigated. METHODS: Ninety-five children who underwent RFCA procedures were stratified according to age (group 1, 0-4 years, n = 24; group 2, 5-9 years, n = 71) and were evaluated retrospectively. RESULTS: Among the 95 patients, atrioventricular reentrant tachycardia was 78.9%, atrioventricular nodal reentrant tachycardia was 10.5%, and ectopic atrial tachycardia was 8.4%. The acute success rate of RFCA was 97.9% and the recurrence rate was 11.6%. RFCA was performed for different main reasons in each group, including drug-resistant tachycardia (37.5% in group 1 vs 7% in group 2; P = 0.001) and symptomatic tachycardia (4.2% in group 1 vs 57.7% in group 2; P < 0.001). There was no significant difference in success rate, recurrence rate, and procedure and fluoroscopy duration between the two groups. The acute success rates did not differ significantly between patients with a single accessory pathway (AP) and those with multiple APs; however, failure or recurrence was more common in the patients with multiple APs (38.5% vs 11.5%; P = 0.01). The multiple APs were found frequently on the right side (P = 0.005). Septal dyskinesia with left ventricular dysfunction in Wolff-Parkinson-White syndrome and tachycardia-induced cardiomyopathy improved after RFCA. CONCLUSIONS: RFCA was found to be effective and safe for SVT in young children.
No takes yet. Share an insight, caveat, or question.
An et al. (2013) conducted a cohort in Supraventricular tachycardia (SVT) (n=95). Radiofrequency catheter ablation (RFCA) vs. Age 5-9 years (compared to age 0-4 years) was evaluated on Acute success rate and recurrence rate. Radiofrequency catheter ablation for SVT in children aged 0-9 years achieved a 97.9% overall acute success rate and 11.6% recurrence rate, with no significant differences in success or recurrence between children aged 0-4 and 5-9 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: